AdvisorNet Financial, Inc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$40,042
+4173.4%
447
+3963.6%
0.00%
Q2 2023$937
+25.8%
11
+22.2%
0.00%
Q1 2023$745
-13.9%
9
-18.2%
0.00%
Q4 2022$865
-98.6%
11
-98.8%
0.00%
-100.0%
Q2 2021$60,000
-40.0%
9000.0%0.00%
-42.9%
Q1 2021$100,000
-6.5%
9000.0%0.01%
-22.2%
Q4 2020$107,000
+35.4%
9000.0%0.01%
+28.6%
Q3 2020$79,000
-2.5%
9000.0%0.01%0.0%
Q2 2020$81,000
+8000.0%
900
+5525.0%
0.01%
Q1 2018$1,000160.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders